Carbylan Therapeutics, Inc. (NASDAQ:CBYL) belongs to Healthcare sector. Its weekly performance is -2.36%. On last trading day company shares ended up $6.61. Carbylan Therapeutics, Inc. (NASDAQ:CBYL) distance from 50-day simple moving average (SMA50) is -9.47%. Wedbush reiterated their outperform rating on shares of Carbylan Therapeutics (NASDAQ:CBYL) in a research note released on Tuesday morning. They currently have a $21.00 target price on the specialty pharmaceutical company’s stock.
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares advanced 0.19% in last trading session and ended the day at $15.66. NVIV return on assets is -155.50%. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) quarterly performance is 38.34%. InVivo Therapeutics Holdings Corp. (NVIV) announced that Richard Layer Ph.D. Director of Research gave a poster presentation at the National Neurotrauma Society (NNS) 2015 Symposium held June 28 – July 1 2015 in Santa Fe NM. The abstract titled “Biodegradable Neuro-Spinal Scaffold Preserves Spinal Cord Architecture Following Spinal Contusion Injury in Rats” was chosen by the NNS Abstract Committee for poster presentation on the basis of quality and scientific merit.
On 02 July, Lincoln National Corporation (NYSE:LNC) shares decreased -0.99% and was closed at $59.14. LNC EPS growth in last 5 year was 40.70%. Lincoln National Corporation (NYSE:LNC) year to date (YTD) performance is 3.29%. Lincoln Financial Group (NYSE:LNC) announced that it will report its second quarter earnings after market close on Wednesday, July 29, 2015. A conference call is scheduled for Thursday, July 30, 2015, at 10:00 a.m. Eastern Time, to discuss second quarter earnings and related matters for the company and its business segments.
Rogers Communications Inc. (NYSE:RCI) ended the last trading day at $35.63. Company weekly volatility is calculated as 1.05%. Rogers Communications Inc. (NYSE:RCI) showed a weekly performance of 0.93%. Rogers Communications, (NYSE:RCI) said that it received all requisite governmental, creditor and court approvals and has completed the acquisitions of both Mobilicity and Shaw’s AWS wireless spectrum as announced last Wednesday, June 24, 2015.
Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) shares advanced 0.64% in last trading session and ended the day at $12.63. VNDA Gross Margin is 89.90% and its return on assets is 7.30%. Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) quarterly performance is 36.10%. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) presented positive results from the long-term maintenance REPRIEVE (Relapse prevention study in patients with schizophrenia) clinical study at the 2015 American Society of Clinical Pharmacology (ASCP) Annual Meeting in Miami Beach, Florida.